CERSI Research Projects
The CERSIs conduct cutting-edge regulatory science research with high public health impact aimed at development of new tools, standards, and approaches to assess the safety, efficacy, quality and performance of FDA-regulated products. Many of these research projects are conducted in collaboration with FDA.
Johns Hopkins University
- Bulk Drug Substances Used to Compound Drugs for Patients with Autism Spectrum Disorder (ASD)
- Patient and Provider Views on Clinical Endpoints: A Qualitative Preference Study of Minimally Invasive Glaucoma Surgical (MIGS) Devices
- More Information..
UCSF-Stanford University
- Source Data Capture from Electronic Health Records (EHRs): Using Standardized Clinical Research Data
- Orthopedic Device Mechanics
- Improving the Efficiency and Rigor of Pharmacovigilance at FDA
- Renal Impairment in New Drug Development
- Effects of Excipients in Generic Drugs Products on Intestinal Drug Transporters
- Next Generation Text Analytics for FDA - Relevant Text Mining
- Chemoinformatic Tools to Predict the Effects of Excipients in Generic Drugs
- Comparing Qualitative and Quantitative Approaches to Eliciting Patient Preferences: A Case Study on Innovative Upper Limb Prostheses
- Patient Reported Outcomes for Minimally Invasive Glaucoma Surgery (MIGS)
- More information..
University of Maryland
- Clinical Use of Drugs Including Bulk Drug Substances Nominated for Use in Compounding by Outsourcing Facilities
- More Information..